Jafra Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-11,184
| Closed | -$927K | – | 99 |
|
|
2018
Q1 | $927K | Buy |
11,184
+5,986
| +115% | +$496K | 0.29% | 70 |
|
|
2017
Q4 | $403K | Sell |
5,198
-14,802
| -74% | -$1.15M | 0.11% | 80 |
|
|
2017
Q3 | $1.23M | Buy |
+20,000
| New | +$1.23M | 0.46% | 56 |
|
|
2017
Q2 | – | Sell |
-12,500
| Closed | -$541K | – | 79 |
|
|
2017
Q1 | $541K | Buy |
+12,500
| New | +$541K | 0.22% | 52 |
|